BioSpace News Archive

- Poster presentation highlights data from the U.S. phase 1 trial of lemzoparlimab, a highly differentiated anti-CD47 monoclonal antibody, for treatment of relapsed or refractory malignancy

Blue Cross Blue Shield of Massachusetts has been named a “Best Company for Dads” by Working Mother in a recognition of the company’s supportive policies. The award celebrates organizations that lead in the areas of parental leave, chi

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its third quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, November 5,

Evofem Biosciences, Inc., (NASDAQ: EVFM) announced today that it has sold $25 million of unsecured convertible promissory notes to funds affiliated with Adjuvant Capital, LP (“Adjuvant Capital”). The notes are convertible into shares of Evofem common stock at a conversion price of $3.65 per share. Proceeds from the sale of the notes

Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading provider of advanced veterinary diagnostic and specialty products, plans to report its third quarter 2020 financial performance in a press release before the market opens on Thursday, November 5, 2020 and to host an earnings call to discuss the results followi

Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services,

entrinsic bioscience (EBS) , a company pioneering a next generation protein modulation technology, today announced that it has been granted U.S. Patent No. (USPN) 10,758,507 (‘507 patent) for novel therapeu

Benz R&D is the leading technologically advanced independent supplier of performance materials and manufacturing technology to the IOL industry

- Lambda significantly accelerated viral decline - Viral clearance highly correlated with baseline viral loads - All Lambda-treated patients were below the infectivity threshold by Day 7

- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its third quarter 2020 financial results and provide an update on the company’s business and outlook on Thursday, October 29, 2020 at 4:30 p.m. (ET) after the closing of the market. The call can be acc